Comparing Lo-Zumandimine vs Nikki
| Lo-Zumandimine (drospirenone / ethinyl estradiol) | Nikki (drospirenone / ethinyl estradiol) |
|
|---|
| Lo-Zumandimine (drospirenone / ethinyl estradiol) | Nikki (drospirenone / ethinyl estradiol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Premenstrual Dysphoric Disorder, Acne, Birth Control. Lo-Zumandimine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Premenstrual Dysphoric Disorder, Acne, Birth Control. Nikki may also be used for purposes not listed in this medication guide. |
Related suggestions Birth Control
Premenstrual Dysphoric Disorder
|
|||||||||||||||
| More about Lo-Zumandimine (drospirenone / ethinyl estradiol) | More about Nikki (drospirenone / ethinyl estradiol) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Be the first to share your experience with this drug. |
Nikki has an average rating of 4.7 out of 10 from a total of 260 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 49% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Lo-Zumandimine side effects |
View all Nikki side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Lower cost generic approved | Lower cost generic approved | ||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Lo-Zumandimine prices |
View all Nikki prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other drospirenone / ethinyl estradiol brands include: Gianvi, Jasmiel, Loryna, Melamisa, Nikki, Ocella, Syeda, Yaela, Yasmin, Yaz, Zarah, Zumandimine View more | Other drospirenone / ethinyl estradiol brands include: Gianvi, Jasmiel, Lo-Zumandimine, Loryna, Melamisa, Ocella, Syeda, Yaela, Yasmin, Yaz, Zarah, Zumandimine View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
32.5 hours |
32.5 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 588 drugs are known to interact with Lo-Zumandimine:
|
A total of 588 drugs are known to interact with Nikki:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
February 27, 2018 |
May 27, 2014 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.